glp-1 for addiction treatment IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target GLP-1 Medications Get at the

Kaiser Family Foundation (2024)

Despite extensive clinical use and post-marketing surveillance involving millions of patients worldwide, a causal link between semaglutide and thyroid C-cell tumors in humans has not been established

If off for too long a period, the medication may not be licensed for you as your BMI may not meet the criteria

Review timing of medication : For oral semaglutide (Rybelsus), ensuring proper administration (on an empty stomach with up to 120 mL of water, then waiting at least 30 minutes before any food, drink, or other oral medicines) may reduce gastrointestinal effects

GLP-1 encourages the pancreas to release insulin only when needed, helping prevent dangerous blood sugar spikes and crashes